Insulet Corporation (PODD)
NASDAQ: PODD · Real-Time Price · USD
143.34
-3.10 (-2.12%)
At close: Aug 14, 2026, 4:00 PM EDT
143.20
-0.14 (-0.10%)
Pre-market: Aug 17, 2026, 7:12 AM EDT
Insulet Employees
Insulet had 5,400 employees as of December 31, 2025. The number of employees increased by 1,500 or 38.46% compared to the previous year.
Employees
5,400
Change (1Y)
1,500
Growth (1Y)
38.46%
Revenue / Employee
$565,444
Profits / Employee
$69,500
Market Cap
9.94B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 5,400 | 1,500 | 38.46% |
| Dec 31, 2024 | 3,900 | 900 | 30.00% |
| Dec 31, 2023 | 3,000 | 400 | 15.38% |
| Dec 31, 2022 | 2,600 | 300 | 13.04% |
| Dec 31, 2021 | 2,300 | 400 | 21.05% |
| Dec 31, 2020 | 1,900 | 550 | 40.74% |
| Dec 31, 2019 | 1,350 | 181 | 15.48% |
| Dec 31, 2018 | 1,169 | 312 | 36.41% |
| Dec 31, 2017 | 857 | 217 | 33.91% |
| Dec 31, 2016 | 640 | -7 | -1.08% |
| Dec 31, 2015 | 647 | 128 | 24.66% |
| Dec 31, 2014 | 519 | 41 | 8.58% |
| Dec 31, 2013 | 478 | -60 | -11.15% |
| Dec 31, 2012 | 538 | -38 | -6.60% |
| Dec 31, 2011 | 576 | 266 | 85.81% |
| Dec 31, 2010 | 310 | 34 | 12.32% |
| Dec 31, 2009 | 276 | -18 | -6.12% |
| Dec 31, 2008 | 294 | 47 | 19.03% |
| Dec 31, 2007 | 247 | -47 | -15.99% |
| Dec 31, 2006 | 294 | 47 | 19.03% |
| Dec 31, 2005 | 247 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| STERIS | 17,937 |
| Zimmer Biomet Holdings | 17,000 |
| Smith & Nephew | 16,988 |
| Bruker | 11,085 |
| Integer Holdings | 11,000 |
| Bio-Rad Laboratories | 7,450 |
| Bio-Rad Laboratories | 7,450 |
| Globus Medical | 6,000 |
PODD News
- 21 hours ago - Insulet participates in a conference call with JPMorgan - TheFly
- 3 days ago - Contact Robbins LLP for Information About Leading the Lawsuit That Alleges Insulet Corporation Misled Investors Regarding the Safety and Reliability of its Insulin Delivery Products - GlobeNewsWire
- 4 days ago - Insulet Corporation Investors With Significant Losses Must Act By August 31, 2026 - GlobeNewsWire
- 5 days ago - SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of August 31, 2026 in Insulet Corporation Lawsuit - PODD - GlobeNewsWire
- 10 days ago - Insulet price target lowered to $175 from $248 at Baird - TheFly
- 10 days ago - Insulet price target lowered to $180 from $190 at Deutsche Bank - TheFly
- 10 days ago - Leerink downgrades Insulet to Market Perform, lowers target to $145 - TheFly
- 10 days ago - Insulet price target lowered to $144 from $294 at TD Cowen - TheFly